Daniels Mark 4
4 · Twist Bioscience Corp · Filed Apr 1, 2021
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Sale
Common Stock
2021-03-31$112.28/sh−1,167$131,031→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-31−1,167→ 36,177 totalExercise: $26.66Exp: 2028-11-18→ Common Stock (1,167 underlying) - Exercise/Conversion
Common Stock
2021-03-31$26.66/sh+1,167$31,112→ 68,093 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.